Cargando…
Modulation of Pathological Pain by Epidermal Growth Factor Receptor
Chronic pain has been widely recognized as a major public health problem that impacts multiple aspects of patient quality of life. Unfortunately, chronic pain is often resistant to conventional analgesics, which are further limited by their various side effects. New therapeutic strategies and target...
Autores principales: | Borges, Jazlyn P., Mekhail, Katrina, Fairn, Gregory D., Antonescu, Costin N., Steinberg, Benjamin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149758/ https://www.ncbi.nlm.nih.gov/pubmed/34054523 http://dx.doi.org/10.3389/fphar.2021.642820 |
Ejemplares similares
-
Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling
por: Sugiyama, Michael G., et al.
Publicado: (2023) -
Akt-ing Up Just About Everywhere: Compartment-Specific Akt Activation and Function in Receptor Tyrosine Kinase Signaling
por: Sugiyama, Michael G., et al.
Publicado: (2019) -
Examining the Underappreciated Role of S-Acylated Proteins as Critical Regulators of Phagocytosis and Phagosome Maturation in Macrophages
por: Dixon, Charneal L., et al.
Publicado: (2021) -
Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis
por: Garay, Camilo, et al.
Publicado: (2015) -
Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment
por: Sasada, Tetsuro, et al.
Publicado: (2016)